PSEUDOMONAS-AERUGINOSA PILI BIND TO ASIALOGM1 WHICH IS INCREASED ON THE SURFACE OF CYSTIC-FIBROSIS EPITHELIAL-CELLS

被引:260
|
作者
SAIMAN, L [1 ]
PRINCE, A [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT PEDIAT,650 W 168TH ST,NEW YORK,NY 10032
来源
JOURNAL OF CLINICAL INVESTIGATION | 1993年 / 92卷 / 04期
关键词
BACTERIAL ADHERENCE; PATHOGENESIS; SIALYLATION;
D O I
10.1172/JCI116779
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The basis for the unique association of Pseudomonas aeruginosa and the cystic fibrosis (CF) lung has remained obscure despite major advances in the understanding of the molecular genetic cause of this disease. There is evidence to suggest that abnormalities in CF transmembrane conductance regulator function result in alterations in the glycosylation of epithelial components. The number of asialoGM1 residues, as representative of a class of glycolipids which contain a GalNAcbeta1-4Gal sequence for P. aeruginosa attachment, was quantified by flow cytometric studies of respiratory epithelial cells in primary culture from both CF patients and normal subjects. Superficial asialoGMI was detected on 12% of the CF cells as compared with 2.9% of the cells from normal control subjects ( P = 0.03, chi2 = 4.73), and more asialoGM1 residues were exposed on CF cells after modification by P. aeruginosa exoproducts. AsialoGM1, but not the sialylated glycolipid GM1, was demonstrated to be a receptor for I-125-labeled P. aeruginosa pilin, a major adhesin for this organism, and exogenous asialoGM1 was found to competitively inhibit P. aeruginosa adherence to epithelial cells, thus, confirming the bioiogical role of the asialoGM1 receptor. Quantitative and qualitative differences in the sialylation of superficial glycolipids in CF epithelial cells may directly contribute to the colonization of the CF lung by P. aeruginosa.
引用
收藏
页码:1875 / 1880
页数:6
相关论文
共 50 条
  • [41] PSEUDOMONAS-AERUGINOSA FLAGELLAR ANTIBODIES IN PATIENTS WITH CYSTIC-FIBROSIS
    ANDERSON, TR
    MONTIE, TC
    MURPHY, MD
    MCCARTHY, VP
    JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (12) : 2789 - 2793
  • [42] INVITRO CONVERSION OF PSEUDOMONAS-AERUGINOSA TO THE CYSTIC-FIBROSIS PHENOTYPE
    SPEERT, DP
    CAMPBELL, ME
    FARMER, SW
    KUO, S
    CLINICAL RESEARCH, 1989, 37 (01): : A191 - A191
  • [43] RISKS OF PSEUDOMONAS-AERUGINOSA CONTAMINATION IN CYSTIC-FIBROSIS PATIENTS
    MOUTERDE, O
    MASSOT, J
    VASSAL, S
    ARCHIVES FRANCAISES DE PEDIATRIE, 1992, 49 (05): : 476 - 477
  • [44] COMMUNICABILITY OF PSEUDOMONAS-AERUGINOSA IN A CYSTIC-FIBROSIS SUMMER CAMP
    SPEERT, DP
    LAWTON, D
    DAMM, S
    JOURNAL OF PEDIATRICS, 1982, 101 (02): : 227 - 229
  • [45] INCREASED ADHERENCE TO HUMAN EPITHELIAL-CELLS OF RESISTANT PSEUDOMONAS-AERUGINOSA STRAINS
    LIANOU, PE
    BASSARIS, HP
    DAIKOS, GK
    KATSORCHIS, TA
    LEGAKIS, NJ
    JOURNAL OF INFECTION, 1980, 2 (04) : 354 - &
  • [46] TREATMENT OF PULMONARY PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS WITH CEFSULODIN
    MOLLER, NE
    KOCH, C
    VESTERHAUGE, S
    JENSEN, K
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1982, 14 (03) : 207 - 211
  • [47] CEFTAZIDIME FOR THE TREATMENT OF PSEUDOMONAS-AERUGINOSA SUPERINFECTIONS IN CHILDREN WITH CYSTIC-FIBROSIS
    LABBE, A
    SABLAYROLLES, B
    DECHAMPS, C
    SIROT, J
    MARTY, N
    ANNALES DE PEDIATRIE, 1986, 33 (07): : 625 - 628
  • [48] PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS - USEFULNESS OF ANTIMICROBIAL THERAPY
    DUTAU, G
    BREMONT, F
    REVUE DES MALADIES RESPIRATOIRES, 1990, 7 (03) : 183 - 185
  • [49] IGG ANTIBODIES IN EARLY PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS
    CORDON, SM
    ELBORN, JS
    RAYNER, RJ
    HILLER, EJ
    SHALE, DJ
    ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (06) : 737 - 740
  • [50] IMMUNIZATION OF NONCOLONIZED CYSTIC-FIBROSIS PATIENTS AGAINST PSEUDOMONAS-AERUGINOSA
    CRYZ, SJ
    WEDGWOOD, J
    LANG, AB
    RUEDEBERG, A
    QUE, JU
    FURER, E
    SCHAAD, UB
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (05): : 1159 - 1162